IDEXX > Companion Animal > Education and Events > Diagnostic Edge Newsletter > January 2005
 

Diagnostic Edge Logo

"We don't send out any CBCs. We use our LaserCyte® machine 24 hours a day to support this clinic and our two outside clinics, because the more we do in-house, the better it is for our patients. I have 100% confidence in this instrument—the speed, the accuracy and the great maintenance."

Jack Austen, PhD
Metairie Small Animal Hospital
Metairie, LA

Visit IDEXX representatives at NAVC to learn about the introduction of the Urine P:C Ratio

 Event: The North American Veterinary Conference Fall Vetlabnotes
 When: January 8–12, 2005
 Where: Orlando, Florida
 Booth: 2111

 
  • News—Hematology thought leaders, IDEXX LaserCyte® customers convene
  • Education—Feline case study: hemolytic anemia
  • Q & A—What is a cPLI?
  • Product News—Introducing urine protein:creatinine testing on the IDEXX VetTest® Chemistry Analyzer and a special Urine P:C Ratio offer!
  • Training Opportunities—LaserCyte® users group at NAVC and other featured IDEXX education and events
  • Technical Tip—Spotting Giardia—infected dogs and cats in-clinic
  • We Want to Hear From You—Calling all qualified urine protein:creatinine/renal disease case studies
  • Diagnostic Edge Archive
Subscribe now to receive this FREE online newsletter.
Download and print this issue of the Diagnostic Edge. (320 KB)

Hematology thought leaders, IDEXX LaserCyte® customers convene at IDEXX

The latest advances in veterinary hematology were the topic of the week at IDEXX headquarters in Westbrook, Maine, recently when academic experts from around the world met up with IDEXX LaserCyte® Hematology Analyzer customers at the third IDEXX Hematology Summit in November. Scheduled events included presentations and discussion sessions, with attendees also taking time for an IDEXX tour and open house with employees.

"There was an interesting dialogue between the thought leaders and our customers," said Hematology Marketing Manager, Brad Brazell. "We learned a lot about how to address the educational needs of the veterinary community—how we can bridge the gap between what practitioners know and what they want to learn."

Attendees of the 2004 IDEXX Hematology Summit


Education

Featured Case Study: Hemolytic Anemia in a Cat

Signalment: Two-year-old, intact female, domestic shorthair cat named Tiffany

Clinical Presentation: Tiffany presented with a sudden onset of depression and anorexia. A mild heart murmur, difficult to characterize during auscultation, was detected, but beyond the relatively severe depression, no obvious physical abnormalities were noted.

In-House Laboratory Findings

Initial CBC Data Assessment:

Red Blood Cells—There was a moderately severe, normocytic and normochromic anemia of unidentified etiology. The potential of an inappropriate nucleated red blood cell response associated with bone marrow stromal damage was strongly considered since there was no morphologic support for strong regenerative anemia (normal MCV and MCHC) that would justify the degree of nucleated red blood cell response.

White Blood Cells—There was a mild leukocytosis characterized by a mature neutrophilia, monocytosis and a basophilia. Changes were most consistent with an inflammatory process associated with a peripheral demand for macrophages (monocytosis).

Platelets—were too clumped to allow accurate enumeration.

Complete Blood Count Results

Test Result Units Reference Range
RBC    3.13 x106/µL 6.0–10.0
Hgb   5.1  g/dL 9.5–15   
Hct  14.8  % 29–45   
MCV  48     fL 41–58   
MCHC  34.2  g/dL 29–36   
nRBC 204     /100 WBC 0–2   
WBC  22.1  x103/µL 4.2–15.6  
Neutrophils  12.9  x103/µL 2.5–12.5  
Lymphocytes   5.6  x103/µL 1.5–7.0   
Monocytes   2.5  x103/µL 0–.85 
Eosinophils    0.21 x103/µL 0–1.5  
Basophils   0.9  x103/µL 0–1.1  
Platelets Clumped x103/µL 170–600    
Reticulocyte   316,130/µL    ‹50,000µL

CBC Data Assessment in Conjunction with a Peripheral Blood-Film Review
(Visit the March 2004 Diagnostic Edge for tips on creating a high-quality blood smear)

Figure 1.
blood smear

Figure 2.
blood smear
Red Blood Cells—Figure 1 and Figure 2, representing a peripheral blood film, illustrate that Tiffany had a strongly regenerative, moderately severe anemia most likely associated with hemolytic disease, based upon the degree of the polychromasia. A manual reticulocyte count of 316,130/µL (normal ‹50,000/µL) provided objective data to support this interpretation. Specific cause for the anemia was not identified; however, a possible immune-mediated component was suspected because of the suggestion of red blood cell agglutination. No infectious etiologic agents were identified; however, underlying Mycoplasma haemofelis (previously Hemobartonella) was maintained high in the differential diagnosis list.

The presence of high numbers of nucleated red blood cells was also confirmed; the degree of polychromasia was much greater than the degree of metarubricytosis, suggesting that primary bone marrow stromal damage was not the cause for the nucleated red blood cell response.

White Blood Cells—Leukocyte distribution as reported in the CBC was validated. No significant leukocyte morphologic abnormalities were noted.

Platelets—Figure 1 and Figure 2 show platelets appearing adequate in number, but as mentioned in the initial data presentation, an accurate enumeration of platelets was not possible because of platelet clumping. Enlarged platelet forms were present, but this is an equivocal finding in the peripheral blood of cats. It may be associated with accelerated thrombopoiesis at the marrow level in response to a peripheral demand for platelets.

Clinical Outcome:

Tiffany was treated with both antibiotic therapy specifically directed against Mycoplasma haemofelis, and immunosuppression to specifically address the probable immune-mediated component to the anemia. Tiffany's clinical condition worsened and the owners elected for euthanasia.

Significant Points Related to This Case:

advantagesAn absolute reticulocyte count and peripheral blood-film evaluation identifying the marked polychromasia, which correlates with the reticulocyte count, was essential in properly characterizing this anemia as strongly regenerative and; therefore, probably hemolytic in origin. The lack of an increased MCV and a decreased MCHC, which is commonly seen with regenerative anemia, could be misleading if interpreted without the reticulocyte count or blood-film evaluation. Many strongly regenerative anemias, or cases where there is a significant reticulocytosis for other reasons, will have high or low normal MCV and MCHC values, respectively, or will actually have MCV and MCHC values outside of the reference range. The presence of significant numbers of reticulocytes in circulation forces these values in their respective directions because these immature red blood cell forms are larger than mature red blood cells and have less hemoglobin content. The primary problem with using these parameters as the sole method of differentiating regenerative from nonregenerative anemia is that they only represent the "mean" cell volume and cell hemoglobin concentration. There may be an adequate reticulocyte response to justify calling an anemia regenerative even though the "mean" of all the circulating erythrocytes does not change enough to bring the values out of the reference range. In addition, there are clinical situations where increased MCV (myelodysplasia) and decreased MCHC (developing iron deficiency) may be seen when there is no evidence of a "regenerative" picture.

The reticulocyte count is considered the most objective and reliable measure of bone marrow responsiveness to accurately classify anemia as to its regenerative status. An added advantage of the IDEXX LaserCyte® Hematology Analyzer profile is that an absolute reticulocyte count is provided with each canine and feline CBC. This valuable information is immediately available to the veterinarian, allowing him/her to answer the first and most important question when an anemia is identified, "is it a regenerative or nonregenerative?"

The suggestion of agglutination on the blood smear provides additional information leading to a logical interpretation that an immune-mediated component to this regenerative anemia may be present. Additional testing, including performing a saline agglutination test and possible Coombs test, would have been required to confirm this suspicion.

Because of the high number of nucleated red blood cells present in this case (204/100 WBC), an accurate instrument leukocyte count would have been impossible with a simple impedance-based hematology analyzer. The nucleated red blood cells would have been enumerated as other nucleated cells, giving a dramatically high false value for the leukocyte count if used without blood-film evaluation and correction for the nucleated red blood cells. The more advanced hematology analyzers utilize other methods such a laser-flow cytometry or enzyme cytochemistry to avoid this limitation. Because of the laser-flow cytometry methodology utilized by LaserCyte and the more advanced reference laboratory analyzers, the greater detailed interrogation of cellular elements allows easy differentiation between nucleated red blood cells and leukocytes. An accurate leukocyte count is possible without additional technical time to "correct" for the nucleated red blood cells whenever they are present.

Submit a Case Study

The recommendations contained in Diagnostic Edge educational materials are intended to provide general guidance only. As with any diagnosis or treatment, you should use clinical discretion with each patient based on a complete evaluation of the patient, including physical presentation and complete laboratory data. With respect to any drug therapy or monitoring program, you should refer to product inserts for a complete description of dosages, indications, interactions and cautions.

This summary was written by Dr. Dennis B. DeNicola of IDEXX Laboratories.

Back to the Top    

Question & Answer

From the canine pancreatitis case study featured in the December 2004 Diagnostic Edge.

Question: I read the pancreatitis case study today and followed it well until we got to the confirming test for acute pancreatitis. I don't know what the cPLI test is. Please enlighten me.

Answer: The test identified as cPLI is a canine pancreas lipase immunoreactivity test developed by Dr. D. Williams and Dr. J. Steiner in the gastroenterology laboratory at the Texas A&M School of Veterinary Medicine. They developed this assay because of relative nonspecificity of other parameters of pancreatic injury that are available for detecting pancreatitis. Lipase values coming from reference laboratory and in-clinic chemistry systems demonstrates greater than 50% specificity of pancreatitis in the dog when the lipase values are greater than 3–4 times the high end of the reference range for that test. Although significant additional research needs to be accomplished, the cPLI test demonstrates greater than 80% specificity (based upon histologically confirmed cases of pancreatitis) in the dog, and therefore, there is significant promise for this test. The fPLI test, specific for feline pancreatic lipase, demonstrates similar promise in Dr. Williams' and Dr. Steiner's hands.

For your information, the following Web site can be further investigated. This is one of the earlier references published regarding the development of both the cPLI and the fPLI tests: www.pubmedcentral.nih.gov.

I hope this answers your question. Please remember, that the diagnosis of pancreatitis in the dog is still somewhat difficult. Never attempt to utilize laboratory testing by itself. The laboratory data is merely there in conjunction with the radiographic or sonographic changes typically seen with pancreatitis to support our clinical impression of pancreatitis.

Dennis B. DeNicola, DVM, PhD, DACVP
Chief Veterinary Educator, IDEXX Laboratories

Michelle Kahn, MS, DVM
Medical Affairs Manager, IDEXX Laboratories

Submit a question to our clinical pathologists.

Back to the Top    

Product News

Early detection of renal disease is now possible on the IDEXX VetTest® Chemistry Analyzer

By the time azotemia is discovered in blood chemistries and renal disease is diagnosed, up to 75% of an animal's kidneys may already be destroyed. While knowing an animal has kidney disease allows you to treat and manage the disease progression, having this knowledge before your patient develops azotemia can be far more advantageous.

For years, researchers have looked for ways to better predict kidney disease. Even small amounts of protein in the urine can be abnormal, and recent research shows that persistent high urine protein:creatinine (UPC) ratios are linked to a poor prognosis in patients.1 The ability to quantify the level of proteinuria in an animal's urine is being recognized as a key tool to helping diagnose and monitor early renal disease.

This is now possible in your clinic with the IDEXX Urine P:C Ratio the first fully quantitative measure of urinary protein loss in-house. This convenient, fast and inexpensive new test for the VetTest® Chemistry Analyzer allows you to diagnose early renal disease, monitor and evaluate treatment, and alter the course of disease to enhance the lives of your patients.

1  Syme HM, Elliot J. Relation of survival time and urine protein excretion in cats with renal and/or hypertension. J Vet Intern Med. 2003;17:405.


Urine P:C RatioSpecial Offer for Our Urine P:C Ratio Users

Buy 24 Urine P:C Ratios (four boxes) and receive a FREE sample preparation kit.

Sample prep kit includes:

  • 50 pipette tips
  • Two pipettors (one 10-µL, one 200-µL)
  • One bottle of solution

Contact your IDEXX distributor for the availability of this special offer.

Back to the Top    

Training Opportunities
 

Education and Events
We offer a variety of seminars and teleconferences about emerging trends and best practices in veterinary diagnostics—in a forum designed to involve, educate and motivate you and your staff.


LaserCyte® Analyzer User Group Session
Become a LaserCyte "super user" in just one afternoon!


Friday, January 7, 2005, 1:00 p.m. to 5:00 p.m.
Marriot World Center
8701 World Center Drive
Orlando, Florida

Back to the Top    

Technical Tip
Spotting Giardia—infected dogs and cats in-clinic

Giardia is a common intestinal parasite of dogs and cats. Infection prevalence can vary to more than 50%, depending on the population, and up to 100% in shelters and kennels.

examplesUnfortunately, Giardia infection is commonly undiagnosed in the clinical setting. Why? One reason is methodology. Clinics have depended on microscopic evaluation of feces to identify Giardia trophozoites or cysts. Technicians know that the fecal float can be used to identify many internal parasites (i.e., roundworms and hookworms), and most parasites are readily identified by any number of in-house diagnostic microscopic methods. Giardia, on the other hand, is almost impossible to diagnose using disposable floatation kits.

Why is the microscopic identification of Giardia sometimes so difficult?

Three reasons.

  1. It is difficult to identify Giardia because, unlike other parasites' eggs, the Giardia cysts are very delicate and are often damaged beyond recognition during preparation of the slide.

  2. If you're not accustomed to identifying the tiny cysts, you can overlook them or confuse them with pollen, yeast and many other artifacts.

  3. The trophozoites and cysts only shed intermittently, which means several fecal examinations may be necessary over several days for an accurate result.

Until now, veterinary technicians have depended on two in-house diagnostic techniques for identifying Giardia:

  • The zinc sulfate floatation technique is used for identifying cysts
  • The trophozoites are seen occasionally on prepared fecal smears
Both procedures are messy, time-consuming and may have many accuracy issues.

In 2004, IDEXX developed the SNAP® Giardia Test on the ELISA platform because of the many problems associated with current methods of diagnosing Giardia.

Detecting Giardia Infection:
A Comparison of In-House Microscopy Method vs. Reference Laboratory Methods

sensitivity and specificity chart

In a recent study, 617 fecal samples were tested for Giardia in the normal course of clinical practice.1 Results from fecal floatation or fecal smears were recorded, and the samples were then forwarded for further reference testing. The results indicated poor performance of current in-house microscopy testing compared to ELISA and DIFM reference methods.

The SNAP Giardia Test provides many advantages for your practice.

  • Easy to set up and run so you can test for Giardia while screening for other fecal parasites
  • Only one sample is required, compared to three for microscopy—making your workflow much faster and easier
  • Includes a unique conjugate-fecal swab that allows for much easier, "hands-off" sampling
  • Fast results (just 8 minutes) so you can identify infected patients during their visits

When should you run a SNAP Giardia Test?

  • Symptomatic animals (i.e., diarrhea, weight loss, etc.)—Anytime you run a fecal float on an animal you suspect has internal parasites, or a sick animal with semi-formed or liquid feces
  • Animals at risk—Animals from shelters and kennels; animals that board frequently, visit doggie-daycare, or that go hiking and camping
  • Confirming Giardia findings on asymptomatic patients—the SNAP Giardia Test can confirm suspect Giardia findings on healthy-pet fecal-float screens

How do you implement the SNAP Giardia Test into your practice?

  • First, have a staff meeting to notify everyone of the protocol change, and then place a reminder to run the test near the slides and coverslips or microscope.
  • Run the SNAP test during the fecal float; all results will be completed together.
  • Change your invoice receipt or computer to include a comprehensive fecal charge.

Example Invoice Printouts:
Comprehensive Fecal $34.00 Comprehensive Fecal $34.00
Fecal Float Roundworms Hookworms
Direct Smear Whipworms Tapeworms
SNAP Giardia Coccidia Giardia

1. Groat R. Survey of clinic practices and testing for diagnosis of Giardia infrections in dogs and cats. Presented at: 2003 ACVIM Forum; June 4–8; Charlotte, NC.

Back to the Top    

We want to hear from you
Calling All Qualified Urine Protein:Creatinine/Renal Disease Case Studies

Do you have a case study in which a urine protein:creatinine ratio helped you detect renal disease? If so, you could win a copy of Renal Disease in Dogs and Cats by Dr. Jonathan Elliott and Dr. Scott Brown, just for sending us a qualified submission!

The case that best exemplifies how clinics can "practice what's possible" will be featured in a special edition case study booklet on renal disease and proteinuria.

Qualified submissions must include:*

  • The patient's name, signalment, history, physical examination, bloodwork and a complete urinalysis (including an IDEXX Urine P:C Ratio result)
  • A diagnosis of renal disease (either primary or secondary)
  • The name, address and telephone number of your clinic; and the names of your veterinarians and veterinary technicians
  • Pictures, if possible

*Limit one case per clinic.

Cases must be submitted to the following address:
Dr. Michelle Kahn
Attention: UPC/Renal Disease Case Study
IDEXX Laboratories
One IDEXX Drive
Westbrook, Maine 04092

If you have any questions, please contact your IDEXX representative or call Dr. Michelle Kahn at 1-207-556-8589.

 

This symbol indicates PDF-formatted materials. To view, you may need to download a free copy of Adobe® Reader® software.

 
© 2008 IDEXX Laboratories, Inc.
All rights reserved.